Opioid Epidemic Initiatives
Comprehensive Opioid Abuse Program (COAP) Solicitation
Applications due June 7, 2018
The Bureau of Justice Assistance (BJA) developed the Comprehensive Opioid Abuse Site-based Program (COAP) in response to the CARA legislation. COAP’s purpose is to provide financial and technical assistance to states, units of local government, and Indian tribal governments to plan, develop, and implement comprehensive efforts to identify, respond to, treat, and support those impacted by the opioid epidemic. Since 2017, the Harold Rogers Prescription Drug Monitoring Program has been incorporated into COAP, emphasizing the important role that PDMPs play in supporting safe prescribing, identifying patients who may be misusing prescription opioids or other prescription drugs, and/or patients who may be at risk for overdose. The FY 2018 COAP solicitation also includes a category of funding supported by a partnership with the Office for Victims of Crime (OVC). Through this funding, applicants can incorporate a victim service and child welfare components into first responder and behavioral health and/or public health partnerships.
There are six grant categories:
- Category 1: First Responder Partnerships—Funding amount: $500,000—$800,000
- Category 2: Technology-Assisted Treatment Projects—Funding amount: $1,000,000
- Category 3: System-Level Diversion Projects—Funding amount: $900,000
- Category 4: Statewide Planning, Coordination, and Implementation Projects—Funding amount: $100,000—$1,300,000
- Category 5: Harold Rogers Prescription Drug Monitoring Program (PDMP) Implementation and Enhancement Projects—Funding amount: $750,000
- Category 6: Public Safety, Behavioral Health, and Public Health Information Sharing Partnerships—Funding amount: $1,000,000—$1,500,000
Stopping the Opioid Crisis Begins at Home
Illinois law enforcement leaders emphasize prevention measures in combatting state-wide crisis.
Opioid abuse and addiction are exacting a grave and growing toll from communities in Illinois and across the country. The death rate from overdoses increases every year, as does the number of babies born with drug dependency. As parents become addicted to prescription painkillers and then — all too often — to cheaper, illegal opioids such as heroin, our foster care system is becoming overburdened. When the costs of this drug scourge to employers and to the health and criminal justice systems are factored in, the estimated annual hit to the U.S. economy has reached an astonishing $504 billion.
REPORT: Law Enforcement Leaders say “Stopping the Opioid Crisis Begins at Home”
PRESS RELEASE: Illinois State’s Attorneys, Sheriffs, and Police Chiefs release report on role of prevention in stemming opioid abuse
On November 1, 2017, the White House announced the release of the Fentanyl Safety Recommendations for First Responders. The Recommendations provide first responders with unified, scientific, evidence-based recommendations to protect themselves when the presence of fentanyl is suspected. The National Sheriffs' Association supports the release of these Recommendations as a critical first step in keeping first responders safe in the field. The Recommendations are the result of a Federal Interagency Working Group coordinated by the White House National Security Council. Stakeholder associations and organizations representing the medical, public health, law enforcement, Fire/EMS, and occupational safety and health disciplines provided invaluable input to inform the Interagency Working Group’s efforts, and their feedback helped ensure the Recommendations are operationally relevant, appropriately tailored to first responders, and conveyed in a user-friendly one-page format. NSA is one of 24 associations/organizations offering collaborative support for the Recommendations.
Download "Fentanyl: Safety Recommendations for First Responders," or visit https://www.whitehouse.gov/ondcp/key-issues/fentanyl for more information.
Read more on Fentanyl from the Drug Enforcement Administration: https://www.dea.gov/druginfo/fentanyl.shtml.
Surgeon General’s Advisory on Naloxone and Opioid Overdose
"I, Surgeon General of the United States Public Health Service, VADM Jerome Adams, am emphasizing the importance of the overdose-reversing drug naloxone. For patients currently taking high doses of opioids as prescribed for pain, individuals misusing prescription opioids, individuals using illicit opioids such as heroin or fentanyl, health care practitioners, family and friends of people who have an opioid use disorder, and community members who come into contact with people at risk for opioid overdose, knowing how to use naloxone and keeping it within reach can save a life."
Handling of Suspected Drugs
NSA released two documents recently:
Diamond Pharmacy Services Releases "Naloxone Use in the Management of Opioid Overdose" in December 2017
Adapt Pharma® Launches Roll Call Training Video to Educate Law Enforcement on NARCAN® (naloxone HCI) Nasal Spray 4mg: Adapt Pharma, Inc. (www.adaptpharma.com) today launched a new roll call training video to educate law enforcement on proper administration of NARCAN® (naloxone HCI) Nasal Spray 4mg to help reverse the effects of an opioid overdose. This roll call instructional video can be downloaded from Narcan.com/LawEnforcementTrainingVideo and customized to include a personalized introduction from law enforcement leadership.
Email release - Are your officers prepared for an accidental opioid emergency?
During the NSA 2017 Annual Education and Technology Expo in Reno, Neveda, Judge Jeanine Pirro hosted a panel featuring Sheriff Keith Cain (Daviess County, KY), Corporal Michael "Duane" Harper (Daviess County, KY), and Dr. Gail Cawkwell, MD, PhD (Chief Medical Officer, Purdue Pharma).
Original air date: April 13, 2017
Drug overdose is the leading cause of accidental death in the US, surpassing traffic fatalities. Opioid use is driving this epidemic. Awareness of prescription abuse and misuse has resulted in people turning to heroin. Heroin is being mixed with ultra potent chemicals and more people are accidentally overdosing and dying.
Opioids have a long history of medicinal and recreational use. They take away pain and activate pleasure sensors in the brain. Too much of an opiate can stop a person's breathing. Naloxone is an opiate receptor blocker that can restore a person's ability to breathe. It can be administered intranasal and can save a person's life. Naloxone is a safe medication that an officer can administer with training. In this webinar, learn how the benefits of an opioid reversal program go beyond just a life-saving intervention and truly embody law enforcement's motto "to protect and to serve".
Presenter: Christopher Cicuto, Clinical Staff Pharmacist, Drug Information Center, Diamond Pharmacy, Indiana, PA